UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 5 | May 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 10 Issue 7
July-2023
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2307983


Registration ID:
522616

Page Number

j670-j676

Share This Article


Jetir RMS

Title

An overview on usage of CO-releasing molecule (CORM) as diverse pharmacological agent.

Authors

Abstract

Carbon monoxide (CO), which is produced as a By-product of heme oxidation by the heme oxygenase(HO) enzyme imparts cytotoxicity in the biological organisms at higher concentrations because binding affinity of CO to hemoglobin when compared to oxygen.so,it was considered to be lethal earlier. In recent days, evidences from extensive research on biological activity has been proved that the release of CO from prodrug CO-releasing molecules (CO-RMs) have significant role in various pharmacological activities when administered in controlled pattern into the cellular systems than direct administration of CO. Based upon the covalent bond formation between CO and metal carbonyl complexes (MCCs) many CORMs are produced such as CORM-1, CORM-2, CORM-3, ALF492, CORM-A1 and ALF186. Inversely, degradation of CORMs generate a metal residue (i-CORMs) which lead to toxicity in the body,Inorder to minimize this effect new CORMats such as micellization, nanoparticles, nanosheet and nanodiamond have been developed. Now a days, inhaled CO (iCO) and hybrid carbon monoxide-releasing molecules (HYCOs) are also used in the therapy of CO. CORM can control the release of CO to a target site, this potential of CO-releasing molecules (CO-RMs) can be useful to formulate CO-based pharmaceuticals This article highlights characteristics of CO-releasing molecules (CO-RMs) and various mechanisms intricated in the therapy of CO when administered in the form of CO-RMs.

Key Words

Cytotoxicity, Carbonmonoxide releasing molecules (CO-RM), Therapy, Target sites

Cite This Article

"An overview on usage of CO-releasing molecule (CORM) as diverse pharmacological agent. ", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 7, page no.j670-j676, July-2023, Available :http://www.jetir.org/papers/JETIR2307983.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"An overview on usage of CO-releasing molecule (CORM) as diverse pharmacological agent. ", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 7, page no. ppj670-j676, July-2023, Available at : http://www.jetir.org/papers/JETIR2307983.pdf

Publication Details

Published Paper ID: JETIR2307983
Registration ID: 522616
Published In: Volume 10 | Issue 7 | Year July-2023
DOI (Digital Object Identifier):
Page No: j670-j676
Country: Telangana, Telangana, India .
Area: Pharmacy
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

000104

Print This Page

Current Call For Paper

Jetir RMS